PL2190984T3 - Sposoby i zestawy do oczyszczania i wykrywania glikozylowanego IgG - Google Patents

Sposoby i zestawy do oczyszczania i wykrywania glikozylowanego IgG

Info

Publication number
PL2190984T3
PL2190984T3 PL08802018T PL08802018T PL2190984T3 PL 2190984 T3 PL2190984 T3 PL 2190984T3 PL 08802018 T PL08802018 T PL 08802018T PL 08802018 T PL08802018 T PL 08802018T PL 2190984 T3 PL2190984 T3 PL 2190984T3
Authority
PL
Poland
Prior art keywords
kits
purification
detection
methods
glycosylated igg
Prior art date
Application number
PL08802018T
Other languages
English (en)
Inventor
Maria Allhorn
Anders Olin
Falk Nimmerjahn
Mattias Collin
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genovis Ab filed Critical Genovis Ab
Publication of PL2190984T3 publication Critical patent/PL2190984T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096—Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL08802018T 2007-09-14 2008-09-11 Sposoby i zestawy do oczyszczania i wykrywania glikozylowanego IgG PL2190984T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96008707P 2007-09-14 2007-09-14
EP08802018.5A EP2190984B1 (en) 2007-09-14 2008-09-11 Methods and kits for purification and detection of glycosylated IgG
PCT/EP2008/007457 WO2009033670A2 (en) 2007-09-14 2008-09-11 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection

Publications (1)

Publication Number Publication Date
PL2190984T3 true PL2190984T3 (pl) 2014-02-28

Family

ID=40076765

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08802018T PL2190984T3 (pl) 2007-09-14 2008-09-11 Sposoby i zestawy do oczyszczania i wykrywania glikozylowanego IgG

Country Status (7)

Country Link
US (1) US8323908B2 (pl)
EP (1) EP2190984B1 (pl)
JP (1) JP5722627B2 (pl)
CN (2) CN102584989B (pl)
DK (1) DK2190984T3 (pl)
PL (1) PL2190984T3 (pl)
WO (1) WO2009033670A2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343895B1 (en) * 2000-12-21 2008-06-18 ID Biomedical Corporation Streptococcus pyogenes antigens and corresponding dna fragments
CN102511007B (zh) 2009-10-02 2015-04-15 罗切格利卡特公司 抗体中的a-岩藻糖基化检测
EP2498812A4 (en) * 2009-11-13 2013-05-22 Bengt Guss IMMUNIZATION COMPOSITION FOR REDUCING STREPTOCOCCAL INFECTIONS
EP3135684B1 (en) 2010-05-26 2023-06-28 Intervacc AB Vaccine against streptococcal infections based on recombinant fusion proteins
GB201103780D0 (en) * 2011-03-04 2011-04-20 Hansa Medical Ab Treatment for ige-mediated disease
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201201314D0 (en) * 2012-01-26 2012-03-07 Isis Innovation Composition
JP6282232B2 (ja) * 2012-02-10 2018-02-21 ユニバーシティー オブ メリーランド，ボルティモア 抗体及びそのＦｃフラグメントの酵素化学的糖鎖改変
TW201404784A (zh) * 2012-07-27 2014-02-01 Univ Nat Chiao Tung 純化蛋白質的方法
DK2991683T3 (da) 2013-05-02 2019-11-04 Glykos Finland Oy Konjugater af et glykoprotein eller en glykan med en toksisk ladning
US10973920B2 (en) 2014-06-30 2021-04-13 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
TWI730972B (zh) * 2015-07-16 2021-06-21 日商第一三共股份有限公司 新穎ＥｎｄｏＳ變異酵素及使用其之經糖鏈重塑之含Fc區域的分子之製造方法
CN105368904A (zh) * 2015-11-30 2016-03-02 苏州康聚生物科技有限公司 一种免疫球蛋白g片段的制备方法及应用
CN105368808B (zh) * 2015-11-30 2019-04-30 苏州康聚生物科技有限公司 一种IdeS蛋白酶、其制备方法及应用
AU2017214441B2 (en) 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases
EP3541835B1 (en) * 2016-11-18 2026-05-13 Biocon Limited Rapid and efficient de-glycosylation of glycoproteins
CN110031632A (zh) * 2019-04-03 2019-07-19 中国医学科学院北京协和医院 一种反映IgG4相关性疾病的疾病活动性的生物标志物及其用途
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
GB202007431D0 (en) 2020-05-19 2020-07-01 Hansa Biopharma AB Cysteine protease
CN111707835B (zh) * 2020-07-01 2022-11-11 珠海丽珠试剂股份有限公司 用于检测IgG4的组合物、试剂盒、应用及检测方法
US20230374542A1 (en) 2020-10-07 2023-11-23 Asklepios Biopharmaceutical, Inc. Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21)
JP2024515626A (ja) 2021-04-16 2024-04-10 アスクレピオス バイオファーマシューティカル， インコーポレイテッド 血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドａａｖビリオン
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
WO2024057095A1 (en) 2022-09-14 2024-03-21 Genovis Ab Mutant protease
CN115873833B (zh) * 2022-11-08 2024-08-16 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺
WO2025256977A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Novel igm and igg cleaving enzymes
WO2025256978A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Variants of igm and igg cleaving enzymes
GB202413764D0 (en) 2024-09-18 2024-10-30 Genovis Ab Immunoglobulin proteases and their uses
WO2026093618A1 (en) 2024-11-04 2026-05-07 F. Hoffmann-La Roche Ag Methods for improving anti-drug antibody assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002212D0 (sv) 1990-06-21 1990-06-21 Hightech Receptor Ab Igg binding protein
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein

Also Published As

Publication number Publication date
CN102584989A (zh) 2012-07-18
WO2009033670A3 (en) 2009-04-30
EP2190984B1 (en) 2013-09-04
US8323908B2 (en) 2012-12-04
US20100317083A1 (en) 2010-12-16
WO2009033670A8 (en) 2009-07-09
DK2190984T3 (da) 2013-12-02
WO2009033670A2 (en) 2009-03-19
JP2010538623A (ja) 2010-12-16
EP2190984A2 (en) 2010-06-02
CN101889082A (zh) 2010-11-17
JP5722627B2 (ja) 2015-05-27
CN102584989B (zh) 2015-05-13

Similar Documents

Publication Publication Date Title
DK2190984T3 (da) Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
GB0816413D0 (en) Purification method and kits
IL188033A0 (en) Method and system for detection of pre-fainting conditions
ZA200806412B (en) Method and installation for the purification of gas
EP2185719A4 (en) RANTES ANTIBODIES AND METHOD FOR THEIR USE
GB0810726D0 (en) systems and methods for monitoring of complex systems
EP2195025A4 (en) THERAPEUTIC ANTIBODY PURIFICATION METHOD AND METHOD OF USE
PL391380A1 (pl) System i sposoby oczyszczania przejściowego gazu technologicznego
GB0525541D0 (en) Detection of antibodies
GB0608190D0 (en) Method of purification
GB0701599D0 (en) Method of detection
SG124371A1 (en) Methods and system for inspection of fabricated components
EP1864329A4 (en) METHODS AND SYSTEMS FOR DETECTING THE PRESENCE OF MATERIALS
IL205244A0 (en) System and method for detection of foreign substances
EP2121042A4 (en) COMPOUNDS AND METHOD FOR THE DETECTION OF CELLS
EP2097731A4 (en) Systems and methods for measurement and analysis of pipeline contaminants
GB0613182D0 (en) Method of detection
GB0605557D0 (en) Method Of Detection
GB0517600D0 (en) Method of detection
GB201101598D0 (en) Purification method and kits
MY143676A (en) Systems and methods for measurement and analysis of pipeline contaminants
GB0611147D0 (en) Method of analysis
GB0609875D0 (en) Sealing means and method of use thereof
HK1140682A (en) Therapeutic antibody purification method and method of use
IL184840A0 (en) Method and system for the measurement of opto-active components concentration